Article
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor…
medRxiv · 2024 · Jacob, J.; Anami, Y.; High, P.; Liang, Z.; Subramanian, S.; Ghosh, S. C.; AghaAmiri, S.; Guernsey-Biddle, C.; Tran, H.; Rowe, J. H.; Azhdarinia, A.; Tsuchikama, K.; Carmon, K. S.
Key facts
| Title | Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer |
|---|---|
| First author | Jacob, J.; Anami, Y.; High, P.; Liang, Z.; Subramanian, S.; Ghosh, S. C.; AghaAmiri, S.; Guernsey-Biddle, C.; Tran, H.; Rowe, J. H.; Azhdarinia, A.; Tsuchikama, K.; Carmon, K. S. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.02.20.581056 |
| Devices mentioned | BK110039 |
| Product codes mentioned | KIT, MVU, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1